Introducing the Chairs at ISCO Congress 2026 – Part 1

oncodaily - International School of Clinical Oncology – ISCO shared a series of posts on Facebook, introducing the Chairs at the upcoming ISCO Congress 2026: 1. “We are delighted to welcome Prof. […]

AI Summary: The ISCO Congress 2026 has unveiled its chairpersons and session lineup, spotlighting leaders shaping the program and key scientific themes. Organizers framed the event as a platform for multidisciplinary exchange and translational oncology priorities, aiming to accelerate research-to-clinic progress while giving attendees plenty to talk about between coffee breaks.


Leadership, training and career-development programs

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Major trial takeaways across 2026 oncology congresses

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Meet the ISCO 2026 Chairs and Honorees

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


Scientific tracks: AI, translational & cellular therapy

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily


All Other Stories

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / oncodaily

2 months / newscientist


Back to Top / Sat, April 25, 2026, 3:21 pm / permalink 22774 / 145 stories in 2 months /




Related Stories


Nature study links adult thymus to longevity and cancer therapy / 3 months

Bowelbabe Fund reaches £20M and announces vaccine initiative / 3 months

Journal retracts study claiming morning immunotherapy benefit / 14 days

Researchers grow liver tissue in patients' bodies; study now under scrutiny / 2 months

AACR names 2026 Distinguished Service Award recipients / 2 months

‘Oslo patient’ reaches HIV remission after rare stem‑cell transplant / 2 months

Ultra‑sensitive ctDNA blood test could personalize breast cancer care for older women / 3 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Infant Health, Trump Administration, Corporate Takeover, Venture Capital and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.